Journal of Clinical Endocrinology & Metabolism, Vol 81, 2502-2507, Copyright © 1996 by Endocrine Society

ARTICLES

Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy

J Hangaard, M Andersen, E Grodum, O Koldkjaer and C Hagen
Department of Endocrinology, Odense University Hospital, Denmark.

The inhibitory action of physiological to pathophysiological serum cortisol levels on TSH secretion were investigated in 12 patients with Addison's disease on 3 occasions. 1) In continuation of the conventional hydrocortisone (HC) substitution, a medium dose of HC (0.5 mg/kg) was infused over 23 h. 2) After 24-h withdrawal of HC, the patients had placebo infusion over 23 h. 3) After 5 days of dexamethasone (1.5 mg/day), a high dose of HC (2.0 mg/kg) was infused over 23 h. Blood sampling was performed every 10 min during the last 10 h of the study period, followed by a TRH test (10 micrograms, iv), To mimic the normal diurnal rhythm for serum cortisol, HC was infused in graduated doses, and during medium dose infusion, the serum cortisol level and the TSH pulsatility pattern were similar to those seen in normal controls. The TSH mean level was 1.0 +/- 0.5 mU/L during medium doses of HC, increasing significantly (P < 0.05) to 2.0 +/- 1.6 mU/L during the low cortisol state and was significantly (P < 0.05) suppressed to 0.4 +/- 0.2 mU/L during high doses of glucocorticoids, when the pulse frequency was also significantly reduced (P < 0.01). Together with a dose-dependent inhibitory action of glucocorticoids on the TSH response to TRH, our data indicate that even physiological serum levels of cortisol have an influence on endogenous TSH secretion, probably caused by regulation of the pituitary sensitivity to TRH.

This article has been cited by other articles:

				H. C. Ho, A. D. Chapital, and M. Yu Hypothyroidism and Adrenal Insufficiency in Sepsis and Hemorrhagic Shock Arch Surg, November 1, 2004; 139(11): 1199 - 1203. [Abstract] [Full Text] [PDF]

				M. I. Surks, E. Ortiz, G. H. Daniels, C. T. Sawin, N. F. Col, R. H. Cobin, J. A. Franklyn, J. M. Hershman, K. D. Burman, M. A. Denke, et al. Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management JAMA, January 14, 2004; 291(2): 228 - 238. [Abstract] [Full Text] [PDF]

				M. H. Samuels Effects of Metyrapone Administration on Thyrotropin Secretion in Healthy Subjects-A Clinical Research Center Study J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3049 - 3052. [Abstract] [Full Text]

				M. H. Samuels Effects of Variations in Physiological Cortisol Levels on Thyrotropin Secretion in Subjects with Adrenal Insufficiency: A Clinical Research Center Study J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1388 - 1393. [Abstract] [Full Text]

				J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen The Effects of Endogenous Opioids and Cortisol on Thyrotropin and Prolactin Secretion in Patients with Addison's Disease J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1595 - 1601. [Abstract] [Full Text]

				J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen Pulsatile Luteinizing Hormone Secretion in Patients with Addison's Disease. Impact of Glucocorticoid Substitution J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 736 - 743. [Abstract] [Full Text]

				L. Ghizzoni, G. Mastorakos, M. E. Street, A. Vottero, G. Mazzardo, M. Vanelli, G. P. Chrousos, and S. Bernasconi Spontaneous Thyrotropin and Cortisol Secretion Interactions in Patients with Nonclassical 21-Hydroxylase Deficiency and Control Children J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3677 - 3683. [Abstract] [Full Text] [PDF]

				M. H. Samuels and P. A. McDaniel Thyrotropin Levels during Hydrocortisone Infusions That Mimic Fasting-Induced Cortisol Elevations: A Clinical Research Center Study J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3700 - 3704. [Abstract] [Full Text] [PDF]